Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson's disease.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Parkinsonism & Related Disorders

• Publication date

  1999-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1353-8020(99)00022-XPMID 18591130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pattern of brain destruction in Parkinson's and Alzheimer's diseases

  2005cited by this paper
• Vimentin immunoreactivity in normal and pathological human brain tissue

  2004cited by this paper
• Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease

  1998cited by this paper
• Inflammatory Signals Induce Neurotrophin Expression in Human Microglial Cells

  1998cited by this paper
• Reactive astrocytes: cellular and molecular cues to biological function.

  1997cited by this paper
• The role of the immune system in neurodegenerative disorders

  1997cited by this paper
• Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function

  1996cited by this paper
• Intermediate filament change in astrocytes following mild cortical contusion

  1996cited by this paper
• Neuropathology of Parkinson's Disease

  1996cited by this paper
• Intermediate filament change in astrocytes following mild cortical contusion.

  1996cited by this paper
• Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury

  1995cited by this paper
• Reactive microglia in cerebral ischaemia: an early mediator of tissue damage?

  1995cited by this paper
• Oxidative damage in neurodegenerative disease.

  1994cited by this paper
• Reactive astrocytes express the embryonic intermediate neurofilament nestin.

  1994cited by this paper
• Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain

  1993cited by this paper
• Cytotoxicity of microglia

  1993cited by this paper
• Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system

  1993cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Divergent effects of astroglial and microglial secretions on neuron growth and survival.

  1992cited by this paper
• Chapter 36: Astrocytes and Parkinson's disease

  1992cited by this paper
• Astrocytes and Parkinson's disease.

  1992cited by this paper
• Quantitative aspects of reactive gliosis: A review

  1992cited by this paper
• Amoeboid and ramified microglia: Their interrelationship and response to brain injury

  1992cited by this paper
• Co-expression of glial fibrillary acidic protein and vimentin in reactive astrocytes following brain injury in rats.

  1991cited by this paper
• Vimentin mRNA expression increases after corticospinal axotomy in the adult hamster

  1991cited by this paper
• Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.

  1991cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989cited by this paper
• The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain

  1989cited by this paper
• Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin

  1988cited by this paper
• Rate of cell death in parkinsonism indicates active neuropathological process

  1988cited by this paper
• Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

  1988cited by this paper
• Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells

  1988cited by this paper
• Increased nigral iron content in postmortem parkinsonian brain.

  1987cited by this paper
• Long-term support by injured brain extract of a subpopulation of ciliary ganglion neurons purified by differential adhesion

  1987cited by this paper
• Medicine and the Law

  1983cited by this paper
• Penicillin-sensitive streptococcal endocarditis.

  1982cited by this paper

• Interconnected roles of astrocytes and the blood–brain barrier in Parkinson’s disease: pathological evidence, mechanistic insights, and knowledge gaps

  2026cites this paper
• Transgenic A53T mice have astrocytic α-synuclein aggregates in dopamine and striatal regions

  2026influential citation
• Astrocytic RNA editing regulates the host immune response to alpha-synuclein

  2025cites this paper
• Optogenetic stimulation of nigral astrocytes is neuroprotective in a 6-OHDA model of neurodegeneration

  2025cites this paper
• NR3C1-mediated epigenetic regulation suppresses astrocytic immune responses in mice

  2025cites this paper
• IGF2‐Reprogrammed Macrophages Ameliorate the Inflammatory Response and Protect Against the Neuroinflammatory Process in Parkinson's Disease Models

  2025cites this paper
• Identification of the abnormalities in astrocytic functions as potential drug targets for neurodegenerative disease

  2024cites this paper
• Physical exercise regulates microglia in health and disease

  2024cites this paper
• Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson’s disease

  2024cites this paper
• Impact of Sex on Neuroimmune contributions to Parkinson's disease.

  2023cites this paper
• 14-3-3γ haploinsufficiency leads to altered dopamine pathway and Parkinson’s disease-like motor incoordination in mice

  2023cites this paper
• Single-cell transcriptomic atlas of the human substantia nigra in Parkinson’s disease

  2022cites this paper
• Dopamine, Immunity, and Disease

  2022cites this paper
• A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology

  2022cites this paper
• Post-mortem brain histological examination in the substantia nigra and subthalamic nucleus in Parkinson’s disease following deep brain stimulation

  2022cites this paper
• Astrogliosis in aging and Parkinson’s disease dementia: a new clinical study with 11C-BU99008 PET

  2022cites this paper
• Immune responses in the Parkinson ’ s disease brain Neurobiology of Disease

  2022cites this paper
• Gastric Helicobacter suis Infection Partially Protects against Neurotoxicity in A 6-OHDA Parkinson’s Disease Mouse Model

  2021cites this paper
• Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease

  2021cites this paper
• Proinflammatory cytokines in Parkinson’s disease and current treatment approaches

  2020cites this paper
• Astrocytes in Parkinson's disease: from preclinical assays to in vivo imaging and therapeutic probes.

  2020cites this paper
• Neuroprotective Effects of Safflower Flavonoid Extract in 6-Hydroxydopamine-Induced Model of Parkinson’s Disease May Be Related to its Anti-Inflammatory Action

  2020cites this paper
• Neuron-Astrocyte Interactions in Parkinson’s Disease

  2020cites this paper
• Sitagliptin and Liraglutide Modulate L-dopa Effect and Attenuate Dyskinetic Movements in Rotenone-Lesioned Rats

  2019cites this paper
• Regional Distributions of Iron, Copper and Zinc and Their Relationships With Glia in a Normal Aging Mouse Model

  2019cites this paper
• Biomarkers of Parkinson's Disease

  2019cites this paper
• Microglial Implication in Parkinson’s Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions?

  2018cites this paper
• Hydrogen peroxide extracellular concentration in the ventrolateral medulla and its increase in response to hypoxia in vitro: Possible role of microglia.

  2018cites this paper
• Mild Inflammatory Profile without Gliosis in the c-Rel Deficient Mouse Modeling a Late-Onset Parkinsonism

  2017cites this paper
• The effect of α-synuclein on gliosis and IL-1α, TNFα, IFNγ, TGFβ expression in murine brain

  2017cites this paper
• Inflammation: Role in Parkinson's Disease and Target for Therapy

  2016cites this paper
• Environmental Toxicants-Induced Immune Responses in the Olfactory Mucosa

  2016cites this paper
• Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.

  2015cites this paper
• Alpha synuclein in Parkinson's disease

  2014cites this paper
• Neuroinflammation and Parkinson’s Disease

  2014cites this paper
• The Role of Astrocytes in Parkinson’s Disease

  2014cites this paper
• Complex II of the mitochondrial respiratory chain is the key mediator of divalent manganese-induced hydrogen peroxide production in microglia.

  2013cites this paper
• The role of inclusions in ALS pathogenesis

  2012cites this paper
• Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis

  2012cites this paper
• The endogenous repair capacity of the parkinsonian brain

  2011cites this paper
• Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders

  2010cites this paper
• Differential activation of astrocytes and microglia during post-natal development of dopaminergic neuronal death in the weaver mouse.

  2003cites this paper
• Inflammatory Mechanisms in Parkinson’s Disease

  2003cites this paper
• Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys.

  2003cites this paper
• Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra.

  2002cites this paper
• Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

  2000cites this paper